Literature DB >> 21849441

Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple trans-repression mechanisms.

Timothy M Hanley1, Gregory A Viglianti.   

Abstract

Sexually transmitted pathogens activate HIV-1 replication and inflammatory gene expression in macrophages through engagement of Toll-like receptors (TLRs). Ligand-activated nuclear receptor (NR) transcription factors, including glucocorticoid receptor (GR), peroxisome proliferator-activated receptor gamma (PPARγ), and liver X receptor (LXR), are potent inhibitors of TLR-induced inflammatory gene expression. We therefore hypothesized that ligand-activated NRs repress both basal and pathogen-enhanced HIV-1 replication in macrophages by directly repressing HIV-1 transcription and by ameliorating the local proinflammatory response to pathogens. We show that the TLR2 ligand PAM3CSK4 activated virus transcription in macrophages and that NR signaling repressed both basal and TLR-induced HIV-1 transcription. NR ligand treatment repressed HIV-1 expression when added concurrently with TLR ligands and in the presence of cycloheximide, demonstrating that they act independently of new cellular gene expression. We found that treatment with NR ligands inhibited the association of AP-1 and NF-κB subunits, as well as the coactivator CBP, with the long terminal repeat (LTR). We show for the first time that the nuclear corepressor NCoR is bound to HIV-1 LTR in unstimulated macrophages and is released from the LTR after TLR engagement. Treatment with PPARγ and LXR ligands, but not GR ligands, prevented this TLR-induced clearance of NCoR from the LTR. Our data demonstrate that both classical and nonclassical trans-repression mechanisms account for NR-mediated HIV-1 repression. Finally, NR ligand treatment inhibited the potent proinflammatory response induced by PAM3CSK4 that would otherwise activate HIV-1 expression in infected cells. Our findings provide a rationale for studying ligand-activated NRs as modulators of basal and inflammation-induced HIV-1 replication.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21849441      PMCID: PMC3187477          DOI: 10.1128/JVI.00789-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  160 in total

1.  Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter.

Authors:  Marina Lusic; Alessandro Marcello; Anna Cereseto; Mauro Giacca
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

Review 2.  The role of sexually transmitted diseases in HIV transmission.

Authors:  Shannon R Galvin; Myron S Cohen
Journal:  Nat Rev Microbiol       Date:  2004-01       Impact factor: 60.633

Review 3.  Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms.

Authors:  Landon Myer; Louise Kuhn; Zena A Stein; Thomas C Wright; Lynette Denny
Journal:  Lancet Infect Dis       Date:  2005-12       Impact factor: 25.071

4.  Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens.

Authors:  N Israël; U Hazan; J Alcami; A Munier; F Arenzana-Seisdedos; F Bachelerie; A Israël; J L Virelizier
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

5.  IL-8 increases transmission of HIV type 1 in cervical explant tissue.

Authors:  Roberto Narimatsu; Dawit Wolday; Bruce K Patterson
Journal:  AIDS Res Hum Retroviruses       Date:  2005-03       Impact factor: 2.205

6.  Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone.

Authors:  Jeffrey Pudney; Alison J Quayle; Deborah J Anderson
Journal:  Biol Reprod       Date:  2005-08-10       Impact factor: 4.285

7.  The Lip lipoprotein from Neisseria gonorrhoeae stimulates cytokine release and NF-kappaB activation in epithelial cells in a Toll-like receptor 2-dependent manner.

Authors:  Philip L Fisette; Sanjay Ram; Jorunn M Andersen; Wen Guo; Robin R Ingalls
Journal:  J Biol Chem       Date:  2003-09-09       Impact factor: 5.157

8.  Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives.

Authors:  R N Fichorova; M Bajpai; N Chandra; J G Hsiu; M Spangler; V Ratnam; G F Doncel
Journal:  Biol Reprod       Date:  2004-05-05       Impact factor: 4.285

9.  PGJ2 antagonizes NF-kappaB-induced HIV-1 LTR activation in colonic epithelial cells.

Authors:  Mélissa Boisvert; Sandra Côté; Amandine Vargas; Stamatoula Pasvanis; Salim Bounou; Benoit Barbeau; Nancy Dumais
Journal:  Virology       Date:  2008-08-27       Impact factor: 3.616

Review 10.  Topical application of entry inhibitors as "virustats" to prevent sexual transmission of HIV infection.

Authors:  Michael M Lederman; Robin Jump; Heather A Pilch-Cooper; Michael Root; Scott F Sieg
Journal:  Retrovirology       Date:  2008-12-18       Impact factor: 4.602

View more
  22 in total

1.  Negative elongation factor (NELF) coordinates RNA polymerase II pausing, premature termination, and chromatin remodeling to regulate HIV transcription.

Authors:  Malini Natarajan; Gillian M Schiralli Lester; Chanhyo Lee; Anamika Missra; Gregory A Wasserman; Martin Steffen; David S Gilmour; Andrew J Henderson
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

Review 2.  Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus.

Authors:  Catalina Méndez; Chantelle L Ahlenstiel; Anthony D Kelleher
Journal:  World J Virol       Date:  2015-08-12

Review 3.  Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs.

Authors:  Joel da Cunha; Luciana Morganti Ferreira Maselli; Ana Carolina Bassi Stern; Celso Spada; Sérgio Paulo Bydlowski
Journal:  World J Virol       Date:  2015-05-12

4.  LXR Alpha Restricts Gammaherpesvirus Reactivation from Latently Infected Peritoneal Cells.

Authors:  P T Lange; C N Jondle; E J Darrah; K E Johnson; V L Tarakanova
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

5.  RON receptor tyrosine kinase, a negative regulator of inflammation, is decreased during simian immunodeficiency virus-associated central nervous system disease.

Authors:  Daniele C Cary; Janice E Clements; Andrew J Henderson
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

Review 6.  Interaction of pathogens with host cholesterol metabolism.

Authors:  Dmitri Sviridov; Michael Bukrinsky
Journal:  Curr Opin Lipidol       Date:  2014-10       Impact factor: 4.776

7.  Selective targeting of the repressive transcription factors YY1 and cMyc to disrupt quiescent human immunodeficiency viruses.

Authors:  Kirston Barton; David Margolis
Journal:  AIDS Res Hum Retroviruses       Date:  2012-09-04       Impact factor: 2.205

8.  Liver X receptor agonist inhibits HIV-1 replication and prevents HIV-induced reduction of plasma HDL in humanized mouse model of HIV infection.

Authors:  Larisa Dubrovsky; Rachel Van Duyne; Svetlana Senina; Irene Guendel; Tatiana Pushkarsky; Dmitri Sviridov; Fatah Kashanchi; Michael Bukrinsky
Journal:  Biochem Biophys Res Commun       Date:  2012-02-04       Impact factor: 3.575

9.  HIV-1 infection is associated with changes in nuclear receptor transcriptome, pro-inflammatory and lipid profile of monocytes.

Authors:  Barbara Renga; Daniela Francisci; Claudio D'Amore; Elisabetta Schiaroli; Adriana Carino; Franco Baldelli; Stefano Fiorucci
Journal:  BMC Infect Dis       Date:  2012-10-29       Impact factor: 3.090

10.  Systematic identification of synergistic drug pairs targeting HIV.

Authors:  Xu Tan; Long Hu; Lovelace J Luquette; Geng Gao; Yifang Liu; Hongjing Qu; Ruibin Xi; Zhi John Lu; Peter J Park; Stephen J Elledge
Journal:  Nat Biotechnol       Date:  2012-10-14       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.